Quality of Life Study for Sickle Cell Patients Treated With Jobelyn (Sorghum Bicolor Extract)

• Status: Unknown status
• Trial end date: 2014-09-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine the antioxidant effect of prolonged use of sorghum bicolor (jobelyn) to increase the level of plasma superoxide dismutase and glutathione reductase in patients with sickle cell disease and to determine if there is any improvement in the quality of life of the patients.

• Phase: Phase 1/Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Lagos State University
• Treatments: Antioxidants; Folic Acid; Proguanil; Vitamin B Complex

Criteria

Inclusion Criteria:

1. AGE : 14 To 40 years

2. SEX: Both sexes

3. Homozygous for the S gene (SS)

Exclusion Criteria:

1. Age below 14 years and above 40 years

2. Evidence of organ failure i.e heart failure, renal failure

3. No consent for study

4. Poor adherence to treatment and irregular visit to the clinic

5. Presence of chronic inflammation

6. Pregnancy